Advertisement

Topics

Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2016 Results

16:15 EST 27 Feb 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Net service revenue of $95.4 million in the fourth quarter increased 11.3% from the comparable prior-year period (backlog conversion rate of 19.9%); Full year 2016 net service revenue of $370.6 million increased 1...

Other Sources for this Article

Medpace Holdings, Inc.
Media Contact:
Mary Kuramoto, 513-579-9911 x2523
m.kuramoto@medpace.com
or
Investor Contact:
investor@medpace.com

NEXT ARTICLE

More From BioPortfolio on "Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2016 Results"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...